Home › Funds › ASR Vermogensbeheer N.V. › JNJ

ASR Vermogensbeheer N.V. position in JNJ

JOHNSON & JOHNSON · Health Care

ASR Vermogensbeheer N.V. reported holding 294,441 shares of JNJ (JOHNSON & JOHNSON) in its Q3 2026 13F filing — a position valued at US$78.0M, representing 0.78% of its reported portfolio and ranking #19 among its reported holdings. ASR Vermogensbeheer N.V. has disclosed JNJ holdings in 7 of the last 7 reported quarters, going back to Q1 2025.

Latest position (Q3 2026)294.44K sh
Reported value held$77.96M
Portfolio Weight0.78%
First reportedQ1 2025
Last changeAdd
Updated2026-10-16

Last updated: 2026-10-16 · Source: SEC EDGAR Form 13F-HR

How ASR Vermogensbeheer N.V.'s JNJ position evolved

ASR Vermogensbeheer N.V. first disclosed a stake in JNJ in Q1 2025 at 228,860 shares (US$38.0M). The position peaked in Q3 2026 at 294,441 shares, worth US$78.0M. Across 7 filings, ASR Vermogensbeheer N.V. increased the stake 4 time(s), trimmed it 0 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 294,441 shares valued at US$78.0M — an increase of 6,208 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q1 2025 228.86K $37.96M New
Q2 2025 240.87K $36.79M Add
Q3 2025 240.12K $44.52M Hold
Q4 2025 283.15K $58.60M Add
Q1 2026 288.66K $70.56M Add
Q2 2026 288.23K $73.20M Hold
Q3 2026 294.44K $77.96M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About JNJ and 13F data

JNJ (JOHNSON & JOHNSON) is a Health Care company. 33 other funds we track also report a position in JNJ — the largest reported positions include BlackRock Inc (US$53.87B), Vanguard Group (US$49.74B), VANGUARD CAPITAL MANAGEMENT LLC (US$39.93B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding JNJ

All JNJ fund holders →

FAQ

How long has ASR Vermogensbeheer N.V. held JNJ?

ASR Vermogensbeheer N.V. has disclosed JNJ holdings in 7 of the last 7 reported quarters, going back to Q1 2025.

What is ASR Vermogensbeheer N.V.'s current position in JNJ?

As of Q3 2026, ASR Vermogensbeheer N.V. holds 294.44K shares of JNJ (JOHNSON & JOHNSON), valued at $77.96M, representing 0.78% of its reported portfolio and ranking #19.

Has ASR Vermogensbeheer N.V. been buying or selling JNJ?

In the latest 13F filing (Q3 2026), ASR Vermogensbeheer N.V. increased its position in JNJ. The position peaked in Q3 2026 at 294.44K shares.

Which other funds hold JNJ?

Other major institutional holders of JNJ include BlackRock Inc, Vanguard Group, VANGUARD CAPITAL MANAGEMENT LLC, among 33 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.